| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BRIEF REPORT |
Endocrine Division (M.E.-M., K.L.-W.), Departments of Internal Medicine, and Obstetrics and Gynecology (I.B., C.H.), Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden; Department of Endocrinology (K.B.), Malmö University Hospital, Lund University, SE-20502 Malmö, Sweden; and Section of Preventive Cardiology (L.W.), Göteborg University, SE-41250 Göteborg, Sweden
Address all correspondence and requests for reprints to: Kerstin Landin-Wilhelmsen, M.D., Ph.D., Endocrine Division, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. E-mail: kerstin.landin{at}sahlgrenska.se.
Turner syndrome (TS) is caused by a sex chromosome aberration. The aim was to study the prevalence and incidence of thyroid disease in adults with TS.
Women with TS (n = 91; mean age, 37.7 ± 11 yr) were compared with an age-matched female random population sample (n = 228). At baseline, 15 (16%) TS women were treated for hypothyroidism, and elevated serum TSH was found in another eight (9%). As a result, hypothyroidism was more common in women with TS (25%) than in controls (2%; P < 0.0001). Serum free T4 was lower (P = 0.02), and serum TSH was higher (P < 0.0001) in TS women than in age-matched controls. Of all TS women with hypothyroidism, 10 (43%) had an elevated thyroid peroxidase antibody titer vs. 15 (22%) of those without hypothyroidism (P < 0.05), evenly distributed between the karyotype 45,X and mosaicism. A high body mass index, but not a family history or blood lipids, was associated with hypothyroidism in TS. After the 5-yr follow-up, an additional 11 (16%) developed hypothyroidism, of whom four (36%) had elevated thyroid peroxidase. Altogether, 34 (37%) TS women had hypothyroidism after the 5-yr follow-up.
Autoimmune hypothyroidism was common, with an annual incidence of 3.2% in TS. Thyroid function should be checked regularly in TS.
This article has been cited by other articles:
![]() |
B. E. Hjerrild, K. H. Mortensen, and C. H. Gravholt Turner syndrome and clinical treatment Br. Med. Bull., June 1, 2008; 86(1): 77 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bondy and for The Turner Syndrome Consensus Study Group Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 10 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stochholm, S. Juul, K. Juel, R. W. Naeraa, and C. Hojbjerg Gravholt Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3897 - 3902. [Abstract] [Full Text] [PDF] |
||||
![]() |
M D C Donaldson, E J Gault, K W Tan, and D B Dunger Optimising management in Turner syndrome: from infancy to adult transfer Arch. Dis. Child., June 1, 2006; 91(6): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cakan and D. Kamat Commentary Clinical Pediatrics, March 1, 2006; 45(2): 192 - 195. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |